Phase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysisAugust 15, 2022
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single CenterAugust 12, 2022
